Pregabalin: A new antiepileptic drug for refractory epilepsy

Seizure

Volumn 15, Issue 2, 2006, Pages 73-78

  Hamandi, Khalid ^a,b   Sander, Josemir W ^a,b  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b EPILEPSY SOCIETY   (United Kingdom)

Author keywords

Anti epileptic drugs; Epilepsy; Pregabalin

Indexed keywords

ANTICONVULSIVE AGENT; CALCIUM CHANNEL; CARBAMAZEPINE; GABAPENTIN; PLACEBO; PREGABALIN;

ABNORMAL THINKING; ACCIDENTAL INJURY; ADD ON THERAPY; AMBLYOPIA; ASTHENIA; ATAXIA; BODY WEIGHT DISORDER; CENTRAL NERVOUS SYSTEM; CLINICAL TRIAL; DIPLOPIA; DIZZINESS; DOSE RESPONSE; DRUG ACTIVITY; DRUG APPROVAL; DRUG EXPOSURE; DRUG INDICATION; DRUG MARKETING; DRUG MECHANISM; DRUG MEGADOSE; DRUG USE; FOCAL EPILEPSY; FOLLOW UP; GENERALIZED ANXIETY DISORDER; HEADACHE; HUMAN; MULTICENTER STUDY; MYOCLONUS; NEUROPATHIC PAIN; NEUROTRANSMITTER RELEASE; POSTMARKETING SURVEILLANCE; PRESYNAPTIC MEMBRANE; PRIORITY JOURNAL; REVIEW; SOMNOLENCE; TREMOR; WEIGHT GAIN;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTICONVULSANTS; CHILD; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG THERAPY, COMBINATION; EPILEPSIES, PARTIAL; GAMMA-AMINOBUTYRIC ACID; HUMANS; MIDDLE AGED; RANDOMIZED CONTROLLED TRIALS; TREATMENT OUTCOME;

EID: 32044466013     PISSN: 10591311     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.seizure.2005.11.005     Document Type: Review

References (21)

1. P. Kwan M.J. Brodie Early identification of refractory epilepsy N Engl J Med 342 2000 314-319
2. C.E. Polkey Clinical outcome of epilepsy surgery Curr Opin Neurol 17 2004 173-178
3. M.C. Walker J.W. Sander Difficulties in extrapolating from clinical trial data to clinical practice: The case of antiepileptic drugs Neurology 49 1997 333-337
4. M. Bialer S.I. Johannessen H.J. Kupferberg R.H. Levy P. Loiseau E. Perucca Progress report on new antiepileptic drugs: A summary of the Sixth Eilat Conference (EILAT VI) Epilepsy Res 51 2002 31-71
5. R.H. Dworkin A.E. Corbin J.P. Young Jr. U. Sharma L. LaMoreaux H. Bockbrader et al. Pregabalin for the treatment of postherpetic neuralgia: A randomized, placebo-controlled trial Neurology 60 2003 1274-1283
6. A.C. Pande J.G. Crockatt D.E. Feltner C.A. Janney W.T. Smith R. Weisler et al. Pregabalin in generalized anxiety disorder: A placebo-controlled trial Am J Psychiatry 160 2003 533-540
7. J.S. Bryans D.J. Wustrow 3-substituted GABA analogs with central nervous system activity: A review Med Res Rev 19 1999 149-177
8. M.J. Field R.J. Oles L. Singh Pregabalin may represent a novel class of anxiolytic agents with a broad spectrum of activity Br J Pharmacol 132 2001 1-4
9. D.J. Dooley C.M. Donovan T.A. Pugsley Stimulus-dependent modulation of [(3)H]norepinephrine release from rat neocortical slices by gabapentin and pregabalin J Pharmacol Exp Ther 295 2000 1086-1093
10. K. Fink D.J. Dooley W.P. Meder N. Suman-Chauhan S. Duffy H. Clusmann et al. Inhibition of neuronal Ca(2+) influx by gabapentin and pregabalin in the human neocortex Neuropharmacology 42 2002 229-236
11. D.J. Dooley C.M. Donovan W.P. Meder S.Z. Whetzel Preferential action of gabapentin and pregabalin at P/Q-type voltage-sensitive calcium channels: Inhibition of K+-evoked [3H]-norepinephrine release from rat neocortical slices Synapse 45 2002 171-190
12. J.C. Fehrenbacher C.P. Taylor M.R. Vasko Pregabalin and gabapentin reduce release of substance P and CGRP from rat spinal tissues only after inflammation or activation of protein kinase C Pain 105 2003 133-141
13. C.P. Taylor M.G. Vartanian Profile of anticonvulsant activity of pregabalin in animal models Epilepsia 38 Suppl. 8 1997 35
14. J. Williamson C.T.E. Lothman E. Bertram Comparison of S-(+)-3 isobutyl GABA (pregabalin) and gabapentin against kindled hippocampal seizures Epilepsia 38 Suppl. 8 1997 29
15. Lyrica© Summary of product characteristics. Pfizer Ltd. 2004.
16. J.A. French A.R. Kugler J.L. Robbins L.E. Knapp E.A. Garofalo Dose-response trial of pregabalin adjunctive therapy in patients with partial seizures Neurology 60 2003 1631-1637
17. S. Arroyo H. Anhut A.R. Kugler C.M. Lee L.E. Knapp E.A. Garofalo Pregabalin add-on treatment: A randomized, double-blind, placebo-controlled, dose-response study in adults with partial seizures Epilepsia 45 2004 20-27
18. A. Beydoun B.M. Uthman A.R. Kugler M.J. Greiner L.E. Knapp E.A. Garofalo Safety and efficacy of two pregabalin regimens for add-on treatment of partial epilepsy Neurology 64 2005 475-480
19. H.J. Huppertz T.J. Feuerstein A. Schulze-Bonhage Myoclonus in epilepsy patients with anticonvulsive add-on therapy with pregabalin Epilepsia 42 2001 790-792
20. J.A. Cramer R. Fisher E. Ben-Menachem J. French R.H. Mattson New antiepileptic drugs: Comparison of key clinical trials Epilepsia 40 1999 590-600
21. S.M. LaRoche S.L. Helmers The new antiepileptic drugs: Scientific review JAMA 291 2004 605-614